We performed IHC to examine the expression levels of LMP2, PSME1 and PSME2 in NACI-NSCLC tumor tissue samples before NACI, and to explore their prognostic value in patients with NACI-NSCLC. This evidence concerns the gene PSME1 and non-small cell lung carcinoma.